NOVEL ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR CONCURRENT ESTIMATION AND PHARMACOKINETIC ANALYSIS OF FAVIPIRAVIR AND MOLNUPIRAVIR IN RAT PLASMA

Authors

  • GOPE EDWARD RAJU Research Scholar, Department of Pharmaceutical Analysis, Dr. Samuel George Institute of Pharmaceutical Sciences, Markapur, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India
  • SRIKANTH POTTENDLA Department of Pharmacology, Dr. Samuel George, Institute of Pharmaceutical Sciences, Markapur, Andhra Pradesh, India
  • SUNEETHA YAPARTHI Department of Pharmaceutical Chemistry, Dr. Samuel George, Institute of Pharmaceutical Sciences, Markapur, Andhra Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2025v18i2.53662

Keywords:

Favipiravir, Molnupiravir, Ultra performance liquid chromatography, Validation, International Council for Harmonisation guidelines

Abstract

Objectives: The objective of this study was to establish a rapid and sensitive ultra-performance liquid chromatography (UPLC) method for the simultaneous estimation of molnupiravir and favipiravir in rat plasma using nirmatrelvir as internal reference.

Methods: The separation was performed on Waters Acquity UPLC BEH C18 (100 mm × 2.1 mm, 1.7 μm) by isocratic elution with a buffer containing 1 mL of formic acid in 1 L of water and the mixer of two components such as buffer and acetonitrile in the ratio of 70:30 as mobile phase with flow rate was 0.3 mL/min at ambient temperature.

Results: Analysis was carried out within 3 min over a good linear concentration range from 100 ng/mL to 4000 ng/mL for both drugs of favipiravir (r2=0.9999±0.018) and molnupiravir (r2=0.9998±0.006). This method has been successfully applied, exploring favipiravir (3.33 mg/kg) and molnupiravir (3.33 mg/kg) with internal standard nirmatrelvir extracted from rat plasma using liquid–liquid extraction.

Conclusion: The drugs were stable throughout the stability studies according to US Food and Drug Administration guidelines, just because, the validated approach has successfully conducting to the pharmacokinetic studies of two drugs.

Downloads

Download data is not yet available.

References

Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450-2. doi: 10.1038/s41591-020-0820-9, PMID: 32284615

Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15(3):359- 86. doi: 10.1007/s11481-020-09944-5, PMID: 32696264

Du YX, Chen XP. Favipiravir: Pharmacokinetics and concerns about clinical trials for 2019-nCoV infection. Clin Pharmacol Ther. 2020;108(2):242-7. doi: 10.1002/cpt.1844, PMID: 32246834

Kausar S, Said Khan F, Ishaq Mujeeb Ur Rehman M, Akram M, Riaz M, Rasool G, et al. A review: Mechanism of action of antiviral drugs. Int J Immunopathol Pharmacol. 2021;35:1-12. doi: 10.1177/20587384211002621, PMID: 33726557

Yin H, Jiang N, Shi W, Chi X, Liu S, Chen JL, et al. Development and effects of influenza antiviral drugs. Molecules. 2021;26(4):810. doi: 10.3390/molecules26040810, PMID: 33557246

Lampejo T. Influenza and antiviral resistance: An overview. Eur J Clin Microbiol Infect Dis. 2020;39(7):1201-8. doi: 10.1007/s10096-020- 03840-9, PMID: 32056049

Xie Y, Choi T, Al-Aly Z. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: A cohort study. Lancet Infect Dis. 2024;24(3):239-55. doi: 10.1016/S1473- 3099(23)00684-9, PMID: 38104583

Wu J, Gong P. Visualizing the nucleotide addition cycle of viral RNA-dependent RNA polymerase. Viruses. 2018;10(1):24. doi: 10.3390/ v10010024, PMID: 29300357

Venkataraman S, Prasad BV, Selvarajan R. RNA dependent RNA polymerases: Insights from structure, function and evolution. Viruses. 2018;10(2):76. doi: 10.3390/v10020076, PMID: 29439438

Lai KY, George Ng WY, Cheng FF. Human Ebola virus infection in West Africa: A review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infect Dis Poverty. 2014;3:43. doi: 10.1186/2049-9957-3-43, PMID: 25699183

Sogoba N, Feldmann H, Safronetz D. Lassa fever in West Africa: Evidence for an expanded region of endemicity. Zoonoses Public Health. 2012;59(Suppl 2):43-7. doi: 10.1111/j.1863-2378.2012.01469.x, PMID: 22958249

Cerrizuela S, Vega-Lopez GA, Aybar MJ. The role of teratogens in neural crest development. Birth Defects Res. 2020;112(8):584-632. doi: 10.1002/bdr2.1644, PMID: 31926062

Das S, Jayaratne R, Barrett KE. The role of ion transporters in the pathophysiology of infectious diarrhea. Cell Mol Gastroenterol Hepatol. 2018;6(1):33-45. doi: 10.1016/j.jcmgh.2018.02.009, PMID: 29928670

Collinson S, Deans A, Padua-Zamora A, Gregorio GV, Li C, Dans LF, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2020;12(12):CD003048. doi: 10.1002/14651858.CD003048.pub4, PMID: 33295643

Balaban CD, Yates BJ. What is nausea? A historical analysis of changing views. Auton Neurosci. 2017;202:5-17. doi: 10.1016/j. autneu.2016.07.003, PMID: 27450627

Singh P, Yoon SS, Kuo B. Nausea: A review of pathophysiology and therapeutics. Ther Adv Gastroenterol. 2016;9(1):98-112. doi: 10.1177/1756283X15618131, PMID: 26770271

Muncie HL, Sirmans SM, James E. Dizziness: Approach to evaluation and management. Am Fam Physician. 2017;95(3):154-62. PMID: 28145669

Chu EC, Zoubi FA, Yang J. Cervicogenic dizziness associated with craniocervical instability: A case report. J Med Cases. 2021;12(11):451- 4. doi: 10.14740/jmc3792, PMID: 34804305

Priyadarshini I, Akila Devi D. Development and validation of an LC-MS/MS method for the determination of tenofovir and emtricitabine. Int J Appl Pharm. 2024;16:116-23. doi: 10.22159/ijap.2024v16i2.49667

Sentat T, Lucida H, Widyati W, Nasif H, Harahap Y, Harijono P, et al. Development and validation of a bio analytical method for therapeutic drug monitoring of amikacin in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry. Int J Appl Pharm. 2024;16(Special Issue 1):140-4.

Hemanth Kumar AK, Sudha V, Vijayakumar A, Padmapriyadarsini C. Simultaneous method for the estimation of bedaquiline and delamanid in human plasma using high performance liquid chromatography. Int J Pharm Pharm Sci. 2021;13:36-40.Cearum dus as ium quam lat entium

Published

07-02-2025

How to Cite

GOPE EDWARD RAJU, SRIKANTH POTTENDLA, and SUNEETHA YAPARTHI. “NOVEL ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR CONCURRENT ESTIMATION AND PHARMACOKINETIC ANALYSIS OF FAVIPIRAVIR AND MOLNUPIRAVIR IN RAT PLASMA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 2, Feb. 2025, pp. 90-95, doi:10.22159/ajpcr.2025v18i2.53662.

Issue

Section

Original Article(s)